These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 11956102

  • 1. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
    Rabbani SA, Gladu J.
    Cancer Res; 2002 Apr 15; 62(8):2390-7. PubMed ID: 11956102
    [Abstract] [Full Text] [Related]

  • 2. Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428.
    Xing RH, Mazar A, Henkin J, Rabbani SA.
    Cancer Res; 1997 Aug 15; 57(16):3585-93. PubMed ID: 9270032
    [Abstract] [Full Text] [Related]

  • 3. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y, Mazar AP, Lebrun JJ, Rabbani SA.
    Cancer Res; 2002 Aug 15; 62(16):4678-84. PubMed ID: 12183425
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis.
    Xing RH, Rabbani SA.
    Int J Cancer; 1996 Jul 29; 67(3):423-9. PubMed ID: 8707419
    [Abstract] [Full Text] [Related]

  • 5. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A, Soeltl R, Lutz V, Wilhelm OG, Magdolen V, Rojo EE, Hantzopoulos PA, Graeff H, Gänsbacher B, Schmitt M.
    Cancer Gene Ther; 2000 Feb 29; 7(2):292-9. PubMed ID: 10770639
    [Abstract] [Full Text] [Related]

  • 6. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.
    Rabbani SA, Harakidas P, Bowlin T, Attardo G.
    Cancer Res; 1998 Aug 01; 58(15):3461-5. PubMed ID: 9699681
    [Abstract] [Full Text] [Related]

  • 7. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 8. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.
    Shariat SF, Roehrborn CG, McConnell JD, Park S, Alam N, Wheeler TM, Slawin KM.
    J Clin Oncol; 2007 Feb 01; 25(4):349-55. PubMed ID: 17264329
    [Abstract] [Full Text] [Related]

  • 9. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
    Henic E, Sixt M, Hansson S, Høyer-Hansen G, Casslén B.
    Gynecol Oncol; 2006 Apr 01; 101(1):28-39. PubMed ID: 16263158
    [Abstract] [Full Text] [Related]

  • 10. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.
    Int J Oncol; 2006 Apr 01; 28(4):807-14. PubMed ID: 16525628
    [Abstract] [Full Text] [Related]

  • 11. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR, Tang J, Hu G, Lin Y, Mutter W, Tong C, Karumanchi SA, Russell SJ, Sukhatme VP.
    J Natl Cancer Inst; 2006 Jun 07; 98(11):756-64. PubMed ID: 16757700
    [Abstract] [Full Text] [Related]

  • 12. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 07; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 13. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
    Gutova M, Najbauer J, Frank RT, Kendall SE, Gevorgyan A, Metz MZ, Guevorkian M, Edmiston M, Zhao D, Glackin CA, Kim SU, Aboody KS.
    Stem Cells; 2008 Jun 07; 26(6):1406-13. PubMed ID: 18403751
    [Abstract] [Full Text] [Related]

  • 14. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V, Schroeder J, Denkert C, Kristiansen G, Schnorr D, Loening SA, Jung K, Staack A.
    Oncol Rep; 2004 Oct 07; 12(4):909-13. PubMed ID: 15375521
    [Abstract] [Full Text] [Related]

  • 15. Targeting uPA/uPAR in prostate cancer.
    Li Y, Cozzi PJ.
    Cancer Treat Rev; 2007 Oct 07; 33(6):521-7. PubMed ID: 17658220
    [Abstract] [Full Text] [Related]

  • 16. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
    Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA, Wells A.
    Exp Cell Res; 2004 Sep 10; 299(1):91-100. PubMed ID: 15302576
    [Abstract] [Full Text] [Related]

  • 17. Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue.
    Luther T, Magdolen V, Albrecht S, Kasper M, Riemer C, Kessler H, Graeff H, Müller M, Schmitt M.
    Am J Pathol; 1997 Apr 10; 150(4):1231-44. PubMed ID: 9094980
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines.
    Lakka SS, Rajagopal R, Rajan MK, Mohan PM, Adachi Y, Dinh DH, Olivero WC, Gujrati M, Ali-Osman F, Roth JA, Yung WK, Kyritsis AP, Rao JS.
    Clin Cancer Res; 2001 Apr 10; 7(4):1087-93. PubMed ID: 11309361
    [Abstract] [Full Text] [Related]

  • 19. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.
    Achbarou A, Kaiser S, Tremblay G, Ste-Marie LG, Brodt P, Goltzman D, Rabbani SA.
    Cancer Res; 1994 May 01; 54(9):2372-7. PubMed ID: 8162583
    [Abstract] [Full Text] [Related]

  • 20. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
    Pass J, Jögi A, Lund IK, Rønø B, Rasch MG, Gårdsvoll H, Lund LR, Ploug M, Rømer J, Danø K, Høyer-Hansen G.
    Thromb Haemost; 2007 Jun 01; 97(6):1013-22. PubMed ID: 17549305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.